Diuretics act by blocking specific transport functions of the renal tubules leading to an increased excretion of urinary sodium chloride and water. By increasing the amt of NaCl and water there is a decrease in both blood volume and venous pressure leading to a decreased preload, fall in CO and fall in arterial pressure. Diuretics decrease blood pressure or eliminate edema.
Proximal tubule → reabsorbs 65% filtered Na, 85% NAHCO3, 65% K+, 60% water, all glucose and AA. The most important ions in regards to diuretic actions are NaHCO3 (sodium bicarb) and NaCl (sodium choride). The Na+-H+ antiporter movement from lumen then into blood via Na+-K+ transporter is the main driving force for water reabsorption. HCO3- wants to be reabsorbed as well but has poor permeability so via the carbonic anhydrase enzyme it is converted to H2CO3 → OH- + CO2. CO2 quickly diffuses into cell and OH- turns to water with the addition of a proton. CO2 in the cell quickly turns back to H2CO3 then intracellular carbonic anhydrase dissociates it to H+ (for the antiporter) and HCO3-.
The thick ascending loop of henle receives hypertonic filtrate and allows for reabsorption of NaCl without water. Na+ is reabsorbed via Na+/K+/2Cl- cotransporter (NKCC2). Cl- exits basolateral side of cell, Na+ exits via Na+/K+ ATPase on basolateral side and K+ is recycled back to the lumen for the NKCC2 function. There is also additional reabsorption of Na+, Ca2+ and Mg2+ from lumen to the interstitium driven by K+ recycling.
Distal convoluted tubule activity reabsorbs4-8% of filtered NaCl. Na+ enters via Na+/Cl- cotransporter (NCCT) and Na+ exits on basolateral side via Na+/K+ ATPase. Ca2+ is reabsorbed via Na+/Ca2+ exhcnagers.
The collecting duct is the final site of NaCl reabsorption and this determines the final Na+ concentration in the urine. Luminal Na+ enters cell via ENaC and exits basolateral side via Na+/K+ ATPase. K+ is secreted into the lumen. ENaC and K+ movement is under the control of aldosterone. Collecting duct also expresses vasopressin (ADH) channels that controls the permeability of the collecting tubule to water. (without ADH the urine is dilute)
Furosemide is a loop diuretic that selectively inhibits NaCl reabsorption in the thick ascending loop of henle by inhibiting the luminal Na+/K+/Cl- cotransporter (NKCC2). This is called a high-ceiling diuretic b/c water is unable to be reabsorbed therefore it is extremely effective. By inhibiting the reabsorption of NaCl, there is a lowered lumen-positive (K+) potential that would usually come from K+ recycling. The positive potential usually drives divalent cation reabsorption in the loop and therefore by reducing potential, loop diuretics Mg2+ and Ca2+ are unable to be reabsorbed and remain in the filtrate to be excreted. Loop diuretics increase urinary excretion of K+ and titratable acid due to increased delivery of Na+ to the distal tubule and therefore increased action of Na+/K+ exchanger. This predisposes the pt to hypokalemia and metabolic acidosis. All together by decreasing sodium and water reabsorption there is a decrease in renal vascsular resistance and an increase in renal blood flow.
Loop diuretics induce expression of COX-2 which synthesizes prostaglandins from arachidonic acid. The prostaglands appear to mediate the diuretic/natriuretic actions to help increase the electrolyte and fluid excretion. It also has an effect on increased renal blood flow.
Thiazides inhibit NaCl reabsorption in the distal convoluted tubule by blocking the Na+/Cl- cotransporter (NCCT). By allowing more Na+ to make it to the collecting duct, there is the same effect as what happens with loop diuretics where increased action of Na/K ATPase and therefore increased excretion of K+ and acid. By increasing the sodium and water excretion there is a decrease in extracellular volume and a decrease in CO and renal blood flow. Unlike loop diuretics, thiazides are able to increase the reabsorption of calcium preventing kidney stones.
Taken orally with half life of 40hrs – takes 1-3 weeks to produce stable effect. Long term treatment with thiazides will allow for normal plasma volume, but a sustained decrease in peripheral resistance therefore lowering blood pressure.
Hydrochlorothiazide is a thiazide diuretic that used to be the treatment of edema for hepatic cirrhosis, but has since been replaced by spironolactone. Hydrochlorothiazide also used to be used in the management of edema in patients with renal dysfunction, but has since been replaced with loop diuretics (ex. furosemide).
Potassium sparing diuretics are competitive aldosterone antagonists (inhibitors). Therefore these diuretics act on the aldosterone receptors [that activate ENaC (Na+ reabsorber) and ROMK (K+ excreter)] at the late distal and cortical collecting ducts causing salt and water retention. These drug antagonize aldosterone at intracellular cytoplasmic receptor sites preventing the translocation of receptor complex into the nucleus. The levels of aldosterone determine effect of diuretics. The higher the amt of aldosterone the greater the effect of the antagonist/diuretic.
Spironolactone has affinity toward progesterone and androgen receptors where it acts as an antagonist and thereby induces side effects such as gynecomastia, impotence, and menstrual irregulatories. Eplerenone (different K+ sparing diuretic) has low affinity for these receptors therefore is less likely to produce these effects.
2. Triamterene
Both of these drugs cause a small increase in NaCl excretion and are usually initiated due to their antikaliuretic actions to offset the hypokalemia seen with other diuretics (furosemide and thiazides). Both drugs competitively inhibit ENaC at the collecting duct. K+ secretion is inhibited b/c o the loss of Na+ driving force. These drugs DO NOT rely on the presence of aldosterone to function.
Triamterene → metabolized in liver, renal excretion of active form and metabolites
Amiloride → urinary excretion of intact drug
Carbonic anhydrase inhibitors [ACETAZOLAMIDE] inhibit intracellular and extracellular forms of carbonic anhydrase resulting in a reduction of bicarb reabsorption in the proximal convoluted tubules and decrease production of H+ inside the cell therefore decreasing Na+/H+ antiporter activity. This decreases Na+ reabsorption. This drug only has a mild diuretic action b/t bicarb depletion enhances NaCl reabsorption by remainder of nephron.